Point72 Asset Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $160K | Buy |
59,200
+23,384
| +65% | +$63.4K | ﹤0.01% | 1208 |
|
|
2025
Q1 | $80.6K | Buy |
+35,816
| New | +$80.6K | ﹤0.01% | 1181 |
|
|
2024
Q2 | – | Sell |
-1,900
| Closed | -$6.27K | – | 1563 |
|
|
2024
Q1 | $6.27K | Buy |
+1,900
| New | +$6.27K | ﹤0.01% | 1382 |
|
|
2022
Q4 | – | Sell |
-9,829,354
| Closed | -$8.46M | – | 1309 |
|
|
2022
Q3 | $8.46M | Sell |
9,829,354
-206,616
| -2% | -$178K | 0.03% | 513 |
|
|
2022
Q2 | $11.2M | Sell |
10,035,970
-1,459,030
| -13% | -$1.63M | 0.05% | 435 |
|
|
2022
Q1 | $12.9M | Buy |
11,495,000
+885,000
| +8% | +$991K | 0.05% | 408 |
|
|
2021
Q4 | $17M | Buy |
10,610,000
+635,000
| +6% | +$1.02M | 0.07% | 357 |
|
|
2021
Q3 | $24.1M | Sell |
9,975,000
-132,189
| -1% | -$320K | 0.11% | 244 |
|
|
2021
Q2 | $32M | Buy |
10,107,189
+1,830,689
| +22% | +$5.8M | 0.14% | 172 |
|
|
2021
Q1 | $27.9M | Buy |
+8,276,500
| New | +$27.9M | 0.13% | 193 |
|
|
2020
Q4 | – | Sell |
-284,469
| Closed | -$745K | – | 1000 |
|
|
2020
Q3 | $745K | Sell |
284,469
-90,531
| -24% | -$237K | ﹤0.01% | 749 |
|
|
2020
Q2 | $1.15M | Buy |
+375,000
| New | +$1.15M | 0.01% | 629 |
|